These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5869069)

  • 1. [Inactivation of isonicotinic acid hydrazides in the organism of patients and drug resistance of Mycobacterium tuberculosis].
    Vil'derman AM; Finn ER; Evgrafova ZA
    Probl Tuberk; 1965; 43(8):72-5. PubMed ID: 5869069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the inactivation of tubazid in the complex therapy of patients with pulmonary tuberculosis].
    Kartseva TM
    Probl Tuberk; 1970; 48(4):36-9. PubMed ID: 4990498
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of the inactivation of antibacterial drugs and drug resistance of disease agents].
    Rudoĭ NM; Lubenson AS
    Biull Eksp Biol Med; 1969 Feb; 67(2):43-5. PubMed ID: 4980639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the degree of inactivation of preparations of isonicotinic acid hydrazides in tuberculous patients].
    Shefer LB
    Lab Delo; 1966; 5():298-301. PubMed ID: 4168957
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of isonicotinic acid hydrazide in blood serum.
    Björnesjö KB; Jarnulf B
    Scand J Clin Lab Invest; 1967; 20(1):39-40. PubMed ID: 6060349
    [No Abstract]   [Full Text] [Related]  

  • 8. [The importance of the inactivation of phthivazid in the mechanism of resistance to it in Mycobacterium tuberculosis].
    Smirnov AG
    Ter Arkh; 1966 Aug; 38(8):28-32. PubMed ID: 6011765
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-tuberculous initial drug resistance of Mycobacterium tuberculosis in Kenya: a ten-year review.
    Githui WA; Kwamanga D; Chakaya JM; Karimi FG; Waiyaki PG
    East Afr Med J; 1993 Oct; 70(10):609-12. PubMed ID: 8187653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of anti-tuberculosis drug resistance in Botswana.
    Talbot EA; Kenyon TA; Mwasekaga MJ; Moeti TL; Mallon V; Binkin NJ
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):72-7. PubMed ID: 12701838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the method of determining the degree of inactivation of tubazid in tuberculosis patients].
    Girshov BD; Glushachenko GI
    Lab Delo; 1967; 7():418-20. PubMed ID: 4178073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of decalcification in the treatment of tuberculosis. 8. Studies on the effect of decalcification on the course of tuberculosis caused by INH-resistant bacilli].
    Giza T; Hanicka M; Herman T; Jelonek A; Kurdzielewicz J; Rembiesowa H; Rudnik J; Wójciak W
    Gruzlica; 1968 Jun; 36(6):545-50. PubMed ID: 4970099
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI; Korotaev GA
    Ter Arkh; 1969; 41(10):94-7. PubMed ID: 5359356
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis--a review.
    Scior T; Meneses Morales I; Garcés Eisele SJ; Domeyer D; Laufer S
    Arch Pharm (Weinheim); 2002; 335(11-12):511-25. PubMed ID: 12596216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of oxyR in Mycobacterium tuberculosis.
    Deretic V; Song J; Pagán-Ramos E
    Trends Microbiol; 1997 Sep; 5(9):367-72. PubMed ID: 9294894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance among Indochinese refugees with tuberculosis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Jun; 30(22):273-5. PubMed ID: 6789100
    [No Abstract]   [Full Text] [Related]  

  • 19. Interstate outbreak of drug-resistant tuberculosis involving children--California, Montana, Nevada, Utah.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Oct; 32(39):516-8. PubMed ID: 6412065
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-resistant tuberculosis in Turkish children.
    Dilber E; Göçmen A; Kiper N; Ozçelik U
    Turk J Pediatr; 2000; 42(2):145-7. PubMed ID: 10936981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.